# Program Rejuran, Program VITARAN or Program Nucleofill: identify the exact product before comparing quotes

Product identities below come from manufacturer pages; they do not establish VERZO stock, a Thai registration, a treatment plan or a price.

**The key distinction is the exact product and variant, not just the brand name.** Program Rejuran, Program VITARAN and Program Nucleofill are not interchangeable labels for one syringe. Each name covers more than one presentation. A quote that only says “PN skin booster” leaves out the detail needed to compare what is being offered.

## What is actually established?

| Name a patient may hear | What its maker identifies | What that does not tell you |
| --- | --- | --- |
| Program Rejuran | PharmaResearch lists Rejuran, Rejuran i, Rejuran s and Rejuran HB plus separately. Its standard Rejuran product page lists PN as its composition. | Which variant VERZO would propose, how much would be used, or whether another brand gives a better result. |
| Program VITARAN | BR Pharm lists HP VITARAN, HP VITARAN i and HP VITARAN S as separate products. Its HP VITARAN page identifies polynucleotide sodium. | That the i or S version has the same presentation or intended use as the standard version, or that a Korean authorization is a Thai one. |
| Program Nucleofill | Promoitalia names Medium, Strong, Soft Plus and Medium Plus within its range. The same page also lists Touch, which it describes as a cosmetic gel; it must not be treated as an interchangeable injectable presentation. | Which formulation is in a clinic quote. The range page alone cannot confirm the local pack or amount. |

These are identity differences, not a clinical ranking. The manufacturers' public pages are not a head-to-head study, and we have not found a directly comparable outcome measure that would support calling one the universal winner. “PN” in a product description also does not mean the products have identical formulation, presentation or suitability.

## If two quotes use the same brand name, are they comparable?

Not yet. Ask for the **full product and variant name**, the amount and unit in the written plan, and what the quoted price includes. A package size on a manufacturer's website is not automatically the amount planned for an individual patient. Where a clinic lists “Nucleofill” without the variant, a reader cannot reliably compare it with a named Strong or Medium quote. The same principle applies to Rejuran versus Rejuran i, and HP VITARAN versus HP VITARAN i.

The next useful step is to compare the exact written proposals rather than choosing from brand names alone. See VERZO's [Program polynucleotide comparison](/en/services/polynucleotide/compare) for the service paths, then check the relevant [Program Rejuran](/en/services/polynucleotide/rejuran), [Program VITARAN i](/en/services/polynucleotide/vitaran-i) or [Program Nucleofill](/en/services/polynucleotide/nucleofill) page. Product availability, amount, pricing and individual suitability remain unverified by this article.

## Sources and limits

- [PharmaResearch medical-device list](https://pharmaresearch.com/en/product/list.html?code=2) and [standard Rejuran product page](https://pharmaresearch.com/en/product/view.html?code=2&curpage=1&idx=3&srh_cate=1): distinct Rejuran variants and standard PN identity. Manufacturer scope, not VERZO stock or local authorization.
- [BR Pharm product list](https://www.brpharm.com/en/product/?category_code=1910&tpf=product%2Flist) and [HP VITARAN product page](https://brpharm.com/product?category_code=1910&code=642&tpf=product/view): distinct variants and standard-product material. The displayed authorization is from the maker's Korean page, not proof of Thai approval.
- [Promoitalia Nucleofill range](https://webpromoitalia.com/nucleofill-range/): range names only. Manufacturer promotional claims from that page are not used as evidence of comparative outcomes.

---
Canonical: https://verzoclinic.com/en/blog/pn-product-names-before-bangkok-quote